期刊文献+

VSIG4在恶性肿瘤诊治中的研究进展 被引量:4

Research Progress of VSIG4 in Diagnosis and Treatment of Malignant Tumors
原文传递
导出
摘要 VSIG4(the protein V-set and immune globulin domain-containing 4)是一种与巨噬细胞蛋白质相关的新的B7相关免疫球蛋白的Ⅰ型跨膜蛋白,具有抑制T细胞活化的能力,也被称为CRIg(免疫球蛋白超家族)和Z39Ig,在病原体识别和清除中起关键作用。恶性肿瘤中,VSIG4的表达及VSIG4阳性T细胞的增加可能预示更高的侵袭性和复发风险。全文就VSIG4与各肿瘤间的关系作一简要概述,为VSIG4与恶性肿瘤诊治提供参考。 The protein V-set and immunoglobulin domain containing protein 4(VSIG4),also known as CRIg and Z39Ig,is a novel typeⅠtransmembrane protein of B7-related immunoglobulin superfamily and a negative regulator of T cell activation,which plays a key role in pathogen identification and clearance.In malignant tumors,the expression of VSIG4 and the increase of VSIG4 positive T cells may indicate higher aggressiveness and greater risk of recurrence.This article gives a brief overview of the relationship between VSIG4 and various cancer,and provides references for application of VSIG4 in the diagnosis and treatment of malignant tumors.
作者 许世莹 黄煜庆 郑国湾 王佳峰 蒋烈浩 葛明华 XU Shi-ying;HUANG Yu-qing;ZHENG Guo-wan;WANG Jia-feng;JIANG Lie-hao;GE Ming-hua(Second Clinical Medical College,Zhejiang Chinese Medical University,Hangzhou 310053,China;The First People’s Hospital of Xiaoshan District,Hangzhou 311200,China;Zhejiang Provincial People’s Hospital,Hangzhou 310014,China)
出处 《肿瘤学杂志》 CAS 2021年第2期148-152,共5页 Journal of Chinese Oncology
关键词 VSIG4 新型B7相关免疫球蛋白 恶性肿瘤 治疗靶点 VSIG4 novel B7 family-related immune globulin malignant tumor therapeutic target
  • 相关文献

参考文献1

二级参考文献11

共引文献17

同被引文献18

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部